vs
FIDELITY D & D BANCORP INC（FDBC）与KESTRA MEDICAL TECHNOLOGIES, LTD.（KMTS）财务数据对比。点击上方公司名可切换其他公司
FIDELITY D & D BANCORP INC的季度营收约是KESTRA MEDICAL TECHNOLOGIES, LTD.的1.1倍（$24.4M vs $22.6M），FIDELITY D & D BANCORP INC净利率更高（32.5% vs -145.3%，领先177.8%），FIDELITY D & D BANCORP INC自由现金流更多（$24.8M vs $-25.6M）
Fidelity D & D Bancorp Inc是一家总部位于美国的地区性银行控股公司，主要在宾夕法尼亚州东北部开展业务，为个人消费者、小微企业及当地社区客户提供存款账户、消费及商业贷款、抵押贷款、财富管理等综合零售及商业银行服务。
Kestra Medical Technologies（KMTS）是一家专注于微创医疗器械研发、生产与商业化的医疗科技企业，核心产品覆盖介入心脏病学与结构性心脏病治疗领域，市场覆盖北美、欧洲及亚太重点区域，服务全球医疗机构与患者。
FDBC vs KMTS — 直观对比
营收规模更大
FDBC
是对方的1.1倍
$22.6M
净利率更高
FDBC
高出177.8%
-145.3%
自由现金流更多
FDBC
多$50.4M
$-25.6M
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $24.4M | $22.6M |
| 净利润 | $7.9M | $-32.8M |
| 毛利率 | — | 50.6% |
| 营业利润率 | 37.7% | -140.7% |
| 净利率 | 32.5% | -145.3% |
| 营收同比 | 15.0% | — |
| 净利润同比 | 36.1% | — |
| 每股收益（稀释后） | $1.29 | $-0.64 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FDBCKMTS
| Q4 25 | $24.4M | $22.6M | ||
| Q3 25 | $23.5M | $19.4M | ||
| Q2 25 | $23.3M | — | ||
| Q1 25 | $22.0M | — | ||
| Q4 24 | $21.2M | — | ||
| Q3 24 | $20.4M | — | ||
| Q2 24 | $19.7M | — | ||
| Q1 24 | $19.5M | — |
净利润FDBCKMTS
| Q4 25 | $7.9M | $-32.8M | ||
| Q3 25 | $7.3M | $-25.8M | ||
| Q2 25 | $6.9M | — | ||
| Q1 25 | $6.0M | — | ||
| Q4 24 | $5.8M | — | ||
| Q3 24 | $5.0M | — | ||
| Q2 24 | $4.9M | — | ||
| Q1 24 | $5.1M | — |
毛利率FDBCKMTS
| Q4 25 | — | 50.6% | ||
| Q3 25 | — | 45.7% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率FDBCKMTS
| Q4 25 | 37.7% | -140.7% | ||
| Q3 25 | 36.5% | -149.1% | ||
| Q2 25 | 35.5% | — | ||
| Q1 25 | 32.2% | — | ||
| Q4 24 | 31.4% | — | ||
| Q3 24 | 28.2% | — | ||
| Q2 24 | 28.9% | — | ||
| Q1 24 | 29.5% | — |
净利率FDBCKMTS
| Q4 25 | 32.5% | -145.3% | ||
| Q3 25 | 31.2% | -133.3% | ||
| Q2 25 | 29.7% | — | ||
| Q1 25 | 27.2% | — | ||
| Q4 24 | 27.5% | — | ||
| Q3 24 | 24.3% | — | ||
| Q2 24 | 25.0% | — | ||
| Q1 24 | 25.9% | — |
每股收益（稀释后）FDBCKMTS
| Q4 25 | $1.29 | $-0.64 | ||
| Q3 25 | $1.27 | $-0.50 | ||
| Q2 25 | $1.27 | — | ||
| Q1 25 | $1.03 | — | ||
| Q4 24 | $1.00 | — | ||
| Q3 24 | $0.86 | — | ||
| Q2 24 | $0.86 | — | ||
| Q1 24 | $0.88 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $148.1M | $175.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $238.9M | $164.1M |
| 总资产 | $2.7B | $246.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FDBCKMTS
| Q4 25 | $148.1M | $175.4M | ||
| Q3 25 | $142.2M | $201.2M | ||
| Q2 25 | $165.5M | — | ||
| Q1 25 | $211.2M | — | ||
| Q4 24 | $83.4M | — | ||
| Q3 24 | $120.2M | — | ||
| Q2 24 | $78.1M | — | ||
| Q1 24 | $72.7M | — |
股东权益FDBCKMTS
| Q4 25 | $238.9M | $164.1M | ||
| Q3 25 | $229.2M | $184.2M | ||
| Q2 25 | $217.9M | — | ||
| Q1 25 | $211.7M | — | ||
| Q4 24 | $204.0M | — | ||
| Q3 24 | $207.3M | — | ||
| Q2 24 | $195.7M | — | ||
| Q1 24 | $191.6M | — |
总资产FDBCKMTS
| Q4 25 | $2.7B | $246.7M | ||
| Q3 25 | $2.7B | $266.3M | ||
| Q2 25 | $2.7B | — | ||
| Q1 25 | $2.7B | — | ||
| Q4 24 | $2.6B | — | ||
| Q3 24 | $2.6B | — | ||
| Q2 24 | $2.5B | — | ||
| Q1 24 | $2.5B | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $42.4M | $-18.3M |
| 自由现金流经营现金流 - 资本支出 | $24.8M | $-25.6M |
| 自由现金流率自由现金流/营收 | 101.7% | -113.5% |
| 资本支出强度资本支出/营收 | 71.9% | 32.2% |
| 现金转化率经营现金流/净利润 | 5.34× | — |
| 过去12个月自由现金流最近4个季度 | $45.4M | — |
8季度趋势，按日历期对齐
经营现金流FDBCKMTS
| Q4 25 | $42.4M | $-18.3M | ||
| Q3 25 | $8.4M | $-26.3M | ||
| Q2 25 | $12.6M | — | ||
| Q1 25 | $11.7M | — | ||
| Q4 24 | $29.6M | — | ||
| Q3 24 | $9.1M | — | ||
| Q2 24 | $8.7M | — | ||
| Q1 24 | $5.3M | — |
自由现金流FDBCKMTS
| Q4 25 | $24.8M | $-25.6M | ||
| Q3 25 | $2.2M | $-34.4M | ||
| Q2 25 | $6.9M | — | ||
| Q1 25 | $11.5M | — | ||
| Q4 24 | $24.9M | — | ||
| Q3 24 | $7.8M | — | ||
| Q2 24 | $7.2M | — | ||
| Q1 24 | $4.0M | — |
自由现金流率FDBCKMTS
| Q4 25 | 101.7% | -113.5% | ||
| Q3 25 | 9.3% | -177.8% | ||
| Q2 25 | 29.6% | — | ||
| Q1 25 | 52.3% | — | ||
| Q4 24 | 117.3% | — | ||
| Q3 24 | 38.1% | — | ||
| Q2 24 | 36.6% | — | ||
| Q1 24 | 20.7% | — |
资本支出强度FDBCKMTS
| Q4 25 | 71.9% | 32.2% | ||
| Q3 25 | 26.5% | 42.2% | ||
| Q2 25 | 24.4% | — | ||
| Q1 25 | 0.8% | — | ||
| Q4 24 | 22.0% | — | ||
| Q3 24 | 6.3% | — | ||
| Q2 24 | 7.5% | — | ||
| Q1 24 | 6.7% | — |
现金转化率FDBCKMTS
| Q4 25 | 5.34× | — | ||
| Q3 25 | 1.15× | — | ||
| Q2 25 | 1.82× | — | ||
| Q1 25 | 1.95× | — | ||
| Q4 24 | 5.07× | — | ||
| Q3 24 | 1.83× | — | ||
| Q2 24 | 1.76× | — | ||
| Q1 24 | 1.05× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
